Damora Therapeutics, Inc. — All Filings
315 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
4
424B3
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-Q | 10-Q | 0001193125-25-269426 | Nov 6, 2025 | Sep 30, 2025 |
| SCHEDULE 13D/A | — | 0001388325-25-000007 | Oct 9, 2025 | — |
| SCHEDULE 13D/A | — | 0001388325-25-000004 | Sep 25, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-102963 | Aug 5, 2025 | Jun 30, 2025 |
| 4 | 4 | 0000950170-25-094576 | Jul 8, 2025 | Jul 3, 2025 |
| 4 | 4 | 0000950170-25-094572 | Jul 8, 2025 | Jul 3, 2025 |
| 4 | 4 | 0000950170-25-094575 | Jul 8, 2025 | Jul 3, 2025 |
| 4 | 4 | 0000950170-25-088164 | Jun 20, 2025 | Jun 18, 2025 |
| 4 | 4 | 0000950170-25-088165 | Jun 20, 2025 | Jun 18, 2025 |
| 4 | 4 | 0000950170-25-088166 | Jun 20, 2025 | Jun 18, 2025 |
| 4 | 4 | 0000950170-25-088167 | Jun 20, 2025 | Jun 18, 2025 |
| 4 | 4 | 0000950170-25-088163 | Jun 20, 2025 | Jun 18, 2025 |
| 8-K | 8-K | 0000950170-25-088168 | Jun 20, 2025 | Jun 18, 2025 |
| 4 | 4 | 0000950170-25-088162 | Jun 20, 2025 | Jun 18, 2025 |
| 10-Q | 10-Q | 0000950170-25-066884 | May 8, 2025 | Mar 31, 2025 |
| DEF 14A | DEF 14A | 0000950170-25-060552 | Apr 30, 2025 | Jun 18, 2025 |
| DEFA14A | DEFA14A | 0000950170-25-061001 | Apr 30, 2025 | — |
| ARS | ARS | 0000950170-25-061110 | Apr 30, 2025 | Dec 31, 2024 |
| PRE 14A | PRE 14A | 0000950170-25-055354 | Apr 17, 2025 | Jun 18, 2025 |
| 10-K | 10-K | 0000950170-25-041981 | Mar 19, 2025 | Dec 31, 2024 |
| S-8 | S-8 | 0000950170-25-042051 | Mar 19, 2025 | — |
| SCHEDULE 13D/A | — | 0000950170-25-006448 | Jan 16, 2025 | — |
| 4 | 4 | 0000950170-25-002811 | Jan 7, 2025 | Jan 3, 2025 |
| 4 | 4 | 0000950170-25-002812 | Jan 7, 2025 | Jan 3, 2025 |
| 4 | 4 | 0000950170-25-002813 | Jan 7, 2025 | Jan 3, 2025 |
| 4 | 4 | 0000950170-25-002814 | Jan 7, 2025 | Jan 3, 2025 |
| SC 13G/A | SC 13G/A | 0001193125-24-253039 | Nov 7, 2024 | — |
| SC 13G | SC 13G | 0001193125-24-253029 | Nov 7, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-119809 | Nov 1, 2024 | Sep 30, 2024 |
| 3 | 3 | 0000950170-24-114669 | Oct 15, 2024 | Oct 11, 2024 |
| 4 | 4 | 0000950170-24-114680 | Oct 15, 2024 | Oct 11, 2024 |
| 8-K | 8-K | 0000950170-24-114481 | Oct 15, 2024 | — |
| 4 | 4 | 0000950170-24-114385 | Oct 11, 2024 | Oct 9, 2024 |
| 4 | 4 | 0000950170-24-114386 | Oct 11, 2024 | Oct 9, 2024 |
| 4 | 4 | 0000950170-24-114387 | Oct 11, 2024 | Oct 9, 2024 |
| 3 | 3 | 0000950170-24-114347 | Oct 11, 2024 | Oct 7, 2024 |
| 4 | 4 | 0000950170-24-114384 | Oct 11, 2024 | Oct 9, 2024 |
| 8-K | 8-K | 0000950170-24-113091 | Oct 7, 2024 | — |
| 8-K | 8-K | 0000950170-24-107580 | Sep 18, 2024 | Sep 16, 2024 |
| 8-K | 8-K | 0000950170-24-105533 | Sep 11, 2024 | Sep 10, 2024 |
| 8-K | 8-K | 0000950170-24-103957 | Sep 5, 2024 | Aug 29, 2024 |
| SC 13G/A | — | 0001995601-24-000004 | Aug 29, 2024 | — |
| 3 | 3 | 0000950170-24-098036 | Aug 16, 2024 | Aug 12, 2024 |
| 10-Q | 10-Q | 0000950170-24-095383 | Aug 12, 2024 | Jun 30, 2024 |
| SC 13D/A | SC 13D/A | 0001193125-24-167233 | Jun 24, 2024 | — |
| 4 | 4 | 0000950170-24-076183 | Jun 21, 2024 | Jun 20, 2024 |
| 4 | 4 | 0000950170-24-076187 | Jun 21, 2024 | Jun 20, 2024 |
| 4 | 4 | 0000950170-24-076188 | Jun 21, 2024 | Jun 20, 2024 |
| 4 | 4 | 0000950170-24-076191 | Jun 21, 2024 | Jun 20, 2024 |
| 8-K | 8-K | 0000950170-24-076186 | Jun 21, 2024 | Jun 20, 2024 |